{"id":"https://openalex.org/W2048055596","doi":"https://doi.org/10.1016/j.pupt.2012.12.002","title":"Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow\u00ae rapid and PARI LC Plus\u00ae nebulisers in cystic fibrosis patients","display_name":"Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow\u00ae rapid and PARI LC Plus\u00ae nebulisers in cystic fibrosis patients","publication_year":2012,"publication_date":"2012-12-08","ids":{"openalex":"https://openalex.org/W2048055596","doi":"https://doi.org/10.1016/j.pupt.2012.12.002","mag":"2048055596","pmid":"https://pubmed.ncbi.nlm.nih.gov/23232039"},"language":"en","primary_location":{"id":"doi:10.1016/j.pupt.2012.12.002","doi":"https://doi.org/10.1016/j.pupt.2012.12.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.pupt.2012.12.002","pdf_url":null,"source":{"id":"https://openalex.org/S102131606","display_name":"Pulmonary Pharmacology & Therapeutics","issn_l":"1094-5539","issn":["1094-5539","1522-9629"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011256855","display_name":"Mirco Govoni","orcid":"https://orcid.org/0000-0002-7834-7237","observed_orcids":["https://orcid.org/0000-0002-7834-7237"]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Mirco Govoni","raw_affiliation_strings":["Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43100 Parma, Italy. m.govoni@chiesi.com","Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43100 Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43100 Parma, Italy. m.govoni@chiesi.com","institution_ids":["https://openalex.org/I4210162628"]},{"raw_affiliation_string":"Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43100 Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070982242","display_name":"Gianluigi Poli","orcid":"https://orcid.org/0000-0002-3758-7664","observed_orcids":["https://orcid.org/0000-0002-3758-7664"]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gianluigi Poli","raw_affiliation_strings":["Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43100 Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43100 Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023979944","display_name":"Daniela Acerbi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniela Acerbi","raw_affiliation_strings":["Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43100 Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43100 Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011676406","display_name":"Debora Santoro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Debora Santoro","raw_affiliation_strings":["Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43100 Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43100 Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030118395","display_name":"HELEN G. CICIRELLO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128691","display_name":"Chiesi (United States)","ror":"https://ror.org/037dejx04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210128691"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen Cicirello","raw_affiliation_strings":["Chiesi Pharmaceuticals Inc., 9605 Medical Center Drive, Suite 380, Rockville, MD 20850, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiesi Pharmaceuticals Inc., 9605 Medical Center Drive, Suite 380, Rockville, MD 20850, USA","institution_ids":["https://openalex.org/I4210128691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013070694","display_name":"Ottavia Annoni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267631","display_name":"CROSS Research SA (Switzerland)","ror":"https://ror.org/03nqjwm69","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267631"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ottavia Annoni","raw_affiliation_strings":["CROSS Research S.A., via F.A. Giorgioli 14, CH-6864 Arzo, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CROSS Research S.A., via F.A. Giorgioli 14, CH-6864 Arzo, Switzerland","institution_ids":["https://openalex.org/I4405267631"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029140823","display_name":"Jozef Ru\u017ei\u010dka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jozef Ru\u017ei\u010dka","raw_affiliation_strings":["Fakultn\u00e1 nemocnica s poliklinikou Bratislava Ru\u017einov, Ru\u017einovsk\u00e1 6, 826 06, Bratislava, Slovak Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fakultn\u00e1 nemocnica s poliklinikou Bratislava Ru\u017einov, Ru\u017einovsk\u00e1 6, 826 06, Bratislava, Slovak Republic","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5011256855"],"corresponding_institution_ids":["https://openalex.org/I4210162628"],"apc_list":{"value":3730,"currency":"USD","value_usd":3730},"apc_paid":null,"fwci":2.2049,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.88185407,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"26","issue":"2","first_page":"249","last_page":"255"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.4880000054836273,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.4880000054836273,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.3167000114917755,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.18520000576972961,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cystic-fibrosis","display_name":"cystic fibrosis","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa-infection","display_name":"Pseudomonas aeruginosa infection","score":0.9679999947547913},{"id":"https://openalex.org/keywords/pulmonary-drug-delivery","display_name":"pulmonary drug delivery","score":0.6209999918937683},{"id":"https://openalex.org/keywords/plasma-pharmacokinetics","display_name":"plasma pharmacokinetics","score":0.9919999837875366},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.6330000162124634},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5559999942779541},{"id":"https://openalex.org/keywords/aminoglycosides","display_name":"aminoglycosides","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C2778974779","wikidata":"https://www.wikidata.org/wiki/Q1758380","display_name":"Tobramycin","level":4,"score":0.8736562728881836},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8217508792877197},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7905550003051758},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7857909202575684},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.7644364833831787},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6731864213943481},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.6709403991699219},{"id":"https://openalex.org/C2776301714","wikidata":"https://www.wikidata.org/wiki/Q259346","display_name":"Sputum","level":3,"score":0.6209170818328857},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4804798662662506},{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.4446921646595001},{"id":"https://openalex.org/C2781018748","wikidata":"https://www.wikidata.org/wiki/Q927234","display_name":"Bronchodilator","level":3,"score":0.4127296209335327},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3384893536567688},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32474231719970703},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2910717725753784},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.2327863872051239},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.20489400625228882},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.1003110408782959},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.09478169679641724},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.09056887030601501},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.07651627063751221},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.0},{"id":"https://openalex.org/C2775832221","wikidata":"https://www.wikidata.org/wiki/Q422482","display_name":"Gentamicin","level":3,"score":0.0},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.0},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009330","descriptor_name":"Nebulizers and Vaporizers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013183","descriptor_name":"Sputum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014031","descriptor_name":"Tobramycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014031","descriptor_name":"Tobramycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014031","descriptor_name":"Tobramycin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.pupt.2012.12.002","doi":"https://doi.org/10.1016/j.pupt.2012.12.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.pupt.2012.12.002","pdf_url":null,"source":{"id":"https://openalex.org/S102131606","display_name":"Pulmonary Pharmacology & Therapeutics","issn_l":"1094-5539","issn":["1094-5539","1522-9629"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:23232039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23232039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary pharmacology & therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320309888","display_name":"Chiesi Farmaceutici","ror":"https://ror.org/0511bn634"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W29861392","https://openalex.org/W1488126718","https://openalex.org/W1971937804","https://openalex.org/W1984893629","https://openalex.org/W1990987230","https://openalex.org/W1996215008","https://openalex.org/W2030631267","https://openalex.org/W2033434224","https://openalex.org/W2064864100","https://openalex.org/W2079326067","https://openalex.org/W2085033676","https://openalex.org/W2089995900","https://openalex.org/W2099500833","https://openalex.org/W2101219380","https://openalex.org/W2107189796","https://openalex.org/W2111364728","https://openalex.org/W2120857717","https://openalex.org/W2125078269","https://openalex.org/W2133206482","https://openalex.org/W2141019693","https://openalex.org/W2142209182","https://openalex.org/W2155069031","https://openalex.org/W2162860932","https://openalex.org/W2165433253","https://openalex.org/W2170927479","https://openalex.org/W2172285809","https://openalex.org/W2197553214","https://openalex.org/W2317332612","https://openalex.org/W2912727276","https://openalex.org/W2994597783","https://openalex.org/W3106798016","https://openalex.org/W6638240676","https://openalex.org/W6680603983"],"related_works":["https://openalex.org/W1834894137","https://openalex.org/W1984893629","https://openalex.org/W2007313191","https://openalex.org/W2170927479","https://openalex.org/W2607211926","https://openalex.org/W2581432333","https://openalex.org/W2080477062","https://openalex.org/W1995178326","https://openalex.org/W2220692989","https://openalex.org/W2150293034"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}